TG Therapeutics Income from Continuous Operations 2010-2025 | TGTX
TG Therapeutics income from continuous operations for the twelve months ending March 31, 2025 was $0.039B, a 4.97% decline year-over-year.
- TG Therapeutics annual income from continuous operations for 2024 was $0.023B, a 84.52% increase from 2023.
- TG Therapeutics annual income from continuous operations for 2023 was $0.013B, a 105.66% decline from 2022.
- TG Therapeutics annual income from continuous operations for 2022 was $-0.224B, a 35.7% decline from 2021.